Author

Ana Martínez

Consejo Superior de Investigaciones CientíficasORCID 0000-0002-2707-8110Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:deep learning· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:imaging· 1 Assay:proteomics· 1 Approach:statistical model· 1 Organism:zebrafish· 1

Frequent Co-Authors

Adrián Miguel Gómez Pozo· 1 shared Adriana Quijada‐FreireiD· 1 shared Alfonso García‐Rubia· 1 shared Blanca Soler PalaciosiD· 1 shared Carlos Óscar S. SorzanoiD· 1 shared Carlos RocaiD· 1 shared Carmen GiliD· 1 shared Carolina Melero‐Jerez· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Adrián Miguel Gómez Pozo

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyeLifePeer-reviewedFeb 14, 2024

Allosteric modulation of the CXCR4:CXCL12 axis by targeting receptor nanoclustering via the TMV-TMVI domain

Eva M. García‐Cuesta, Pablo Martínez, Karthik Selvaraju…·Mario Mellado

This paper identifies a small molecule that modulates CXCR4 nanoclustering without affecting ligand binding, improving therapeutic potential over existing CXCR4 antagonists.

14 citations

zebrafishproteomics

𝕏 PostBluesky

NeuroscienceInternational Journal of Molecular SciencesPeer-reviewedFeb 28, 2021

Dynamics of central remyelination and treatment evolution in a model of Multiple Sclerosis with Optic Coherence Tomography

Rocío Benítez‐Fernández, Carolina Melero‐Jerez, Carmen Gil…·Fernando de Castro

This study uses optical coherence tomography to monitor remyelination in MS patients and validates the therapeutic potential of VP3.15 as a remyelinating drug.

7 citations

humanimaging

𝕏 PostBluesky